Sigilon Therapeutics, Inc.

SGTX · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$19,621$41,255$42,066$32,925
Short-Term Investments$15,279$15,114$27,560$45,344
Receivables$6,858$4,960$3,458$23
Inventory$250$251$250$0
Other Curr. Assets$2,860$3,067$1,077$2,334
Total Curr. Assets$44,868$64,647$74,411$80,626
Property Plant & Equip (Net)$9,651$10,903$11,833$12,961
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,040$1,038$1,034$1,031
Total NC Assets$10,691$11,941$12,867$13,992
Other Assets$0$0$0$0
Total Assets$55,559$76,588$87,278$94,618
Liabilities
Payables$1,110$1,331$936$1,408
Short-Term Debt$4,523$11,165$11,152$11,129
Tax Payable$0$0$0$0
Deferred Revenue$13,779$12,987$12,885$12,071
Other Curr. Liab.$5,835$3,506$6,021$5,947
Total Curr. Liab.$25,247$28,989$30,994$30,555
LT Debt$2,865$14,305$16,909$19,477
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$233$176
Total NC Liab.$2,865$14,305$17,142$19,653
Other Liabilities$0$0$0$0
Cap. Leases$7,388$8,390$9,373$10,318
Total Liabilities$28,112$43,294$48,136$50,208
Equity
Pref Stock$0$0$0$0
Common Stock$3$32$32$32
Retained Earnings-$271,684-$264,178-$256,800-$250,115
AOCI-$177-$273-$429-$636
Other Equity$299,305$297,713$296,339$295,129
Total Equity$27,447$33,294$39,142$44,410
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$55,559$76,588$87,278$94,618
Net Debt-$12,233-$15,785-$14,005-$2,319